The TALLYHO Mouse as a Model of Human Type 2 Diabetes-Reference-Cited by-同舟云学术

The TALLYHO Mouse as a Model of Human Type 2 Diabetes

Published:2012 Issue: Volume: Page:75-87
ISSN:
Container-title:Animal Models in Diabetes Research
language:
Short-container-title:

Author:

Kim Jung Han,Saxton Arnold M.

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-62703-068-7_6.pdf

Reference48 articles.

1. Gavin JR 3rd, Stolar MW, Freeman JS et al (2010) Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges. J Am Osteopath Assoc 110:S2–S14

2. Belkina AC, Denis GV (2010) Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes 17:472–477

3. Elbein SC (2009) Genetics factors contributing to type 2 diabetes across ethnicities. J Diabetes Sci Technol 3:685–689

4. Freeman H, Cox RD (2006) Type-2 diabetes: a cocktail of genetic discovery. Hum Mol Genet 15:R202–R209

5. Surampudi PN, John-Kalarickal J, Fonseca VA (2009) Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mt Sinai J Med 76:216–226

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibition leads to a restoration of hepatic and circulating metabolites involved in the folate cycle and pyrimidine biosynthesis;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-08-01

2. Design of Animal Experiments in Pharmacological Research;Düzce Tıp Fakültesi Dergisi;2024-06-30

3. L-arginine supplementation abrogates hypoxia-induced virulence of Staphylococcus aureus in a murine diabetic pressure wound model;mSphere;2024-03-26

4. Animal models for type 1 and type 2 diabetes: advantages and limitations;Frontiers in Endocrinology;2024-02-20

5. Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes–Induced Bone Disease;JBMR Plus;2023-11-17